The story of Viagra’s patents and generic entry of sildenafil citrate is a valuable one because it covers many of […]
Viagra: A Complicated Case Study of Generic Drug Market Entry in the United States Read Post »
Drugs can have many patents and regulatory protections Drugs can be covered by myriad patents and regulatory protections. Even Aspirin,
The Rise of Biosimilars in Asia Biosimilars have been making waves across the globe, but nowhere is their impact more
The Rise of China’s Pharmaceutical Industry China’s pharmaceutical industry has undergone a remarkable transformation in recent years. From being primarily
China and Potential Opportunity for Pharmaceutical Investments Read Post »
Gone are the days when a single, widely prescribed drug could sustain a company’s growth and profitability for years. Today,
Evolving Pharmaceutical Strategies in a Post-Blockbuster World Read Post »
India’s pharmaceutical sector stands as a beacon of both immense potential and significant challenges. As the world’s largest provider of
Balancing Opportunity and Risk in India’s Pharmaceutical Sector Read Post »
Personalized medicine tailors medical treatments to individual patients based on their genetic, environmental, and lifestyle factors. However, as with any
Patents for Personalized Medicine: Challenges and Opportunities Read Post »
This article was originally published by Ravi Gupta, Thomas J Bollyky, Matthew Cohen, Joseph S Ross, and Aaron S Kesselheim
Officially known as Approved Drug Products With Therapeutic Equivalence Evaluations, the FDA Orange Book contains a list of drugs considered
3 Uses for Historical Versions of the FDA Orange Book Read Post »
Get fresh news and insights, drug patent expirations & more…
